ProJenX is a biopharmaceutical company that develops novel small molecule therapeutics that target motor neuron degenerative pathways. Founded in 2021, ProJenX is headquartered in New Suffolk.
FOUNDED:
2021
INDUSTRY:
Biopharma, Health Care, Therapeutics
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
